Ghosh Rajesh, Badavath Vishnu Nayak, Chowdhuri Snehasis, Sen Anik
School of Basic Sciences Indian Institute of Technology Bhubaneswar Bhubaneswar India.
Chitkara College of Pharmacy Chitkara University Punjab 140401 India.
ChemistrySelect. 2022 Apr 12;7(14):e202200055. doi: 10.1002/slct.202200055. Epub 2022 Apr 11.
Natural compounds in medicinal plants are best remedies for different diseases and are important to develop new drugs. This work was dedicated to understand the role of different natural compounds of , a well-known herbal plant, in the treating of Covid 19. In this article, we have investigated interactions of such natural compounds from with the main protease (M) of the SARS-CoV-2, which is a key component for cleavage of viral polyprotein, and an important target for the development of drugs towards COVID-19. We have performed molecular docking study on 22 different molecules of and proposed that 7 of the natural compounds (triterpenoids and sterols) interacts with a comparable or stronger interactions than the inhibitor N3. Molecular dynamics simulations (100 ns) revealed that 7 M- complexes are stable, conformationally less fluctuated, slightly less compact, and marginally expanded than ligand-free conformation of M. The intermolecular H-bonding and detailed MM/PBSA and MM-GBSA analysis showed Daucosterol interaction to be the most strong, whereas comparable interactions were observed for Arjunetin, Maslinic acid, and Bellericoside. Our study suggested that these natural compounds can act as potent M inhibitors for SARS-CoV-2, and may evolve as promising anti-COVID-19 drugs in the near future.
药用植物中的天然化合物是治疗各种疾病的最佳药物,对开发新药具有重要意义。这项工作致力于了解一种著名草药植物中不同天然化合物在治疗新冠肺炎方面的作用。在本文中,我们研究了该草药植物中此类天然化合物与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要蛋白酶(M)的相互作用,该蛋白酶是切割病毒多聚蛋白的关键成分,也是开发抗新冠肺炎药物的重要靶点。我们对该草药植物的22种不同分子进行了分子对接研究,并提出其中7种天然化合物(三萜类化合物和甾醇)与抑制剂N3的相互作用相当或更强。分子动力学模拟(100纳秒)表明,7种M-复合物是稳定的,构象波动较小,比M的无配体构象略微不紧凑且略有扩展。分子间氢键以及详细的MM/PBSA和MM-GBSA分析表明,胡萝卜苷的相互作用最强,而阿朱那因、齐墩果酸和β-香树素苷也观察到了类似的相互作用。我们的研究表明,这些天然化合物可作为SARS-CoV-2的有效M抑制剂,并可能在不久的将来发展成为有前景的抗新冠肺炎药物。